The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the ...

At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax’s license by its April 1 ...

Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...

Federal regulators have asked Novavax (NVAX) to conduct another randomized clinical trial of its Covid-19 vaccine following earlier delays in ...

On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...

Just 13 percent of children have gotten the latest Covid shot, according to the most recent CDC data. And after Republicans, ...

EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ saysStay Ahead of the Market: Discover outperforming stocks and ...